NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

11218	Companies
248777	Keywords
176570	Articles
134619	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 04/20/2026 at 08:35, 6 months 3 days ago

Nanobiotix Reveals Enhanced Bioavailability and Reduced Toxicity in Preclinical Study

Preclinical Study Bioavailability NANOBIOTIX Nanoprimer Technology LNP Immunotherapy
PRESS RELEASE

published on 04/20/2026 at 08:30, 6 months 3 days ago

Nanobiotix annonce de nouvelles données précliniques démontrant une amélioration de la biodisponibilité systémique et la réduction de la toxicité pour des immunothérapies à ADN delivrées par LNP après traitement avec sa technologie de nan
Nanobiotix annonce de nouvelles données précliniques démontrant une amélioration de la biodisponibilité systémique et la réduction de la toxicité pour des immunothérapies à ADN délivrées par LNP après traitement avec sa technologie de Nanoprimer

NANOBIOTIX Immunothérapies Biodisponibilité Données Précliniques Toxicité
PRESS RELEASE

published on 04/20/2026 at 08:30, 6 months 3 days ago

Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
Nanobiotix presents new preclinical data at AACR 2026 showcasing Nanoprimer technology enhancing systemic bioavailability and reducing toxicity for LNP-delivered DNA immunotherapy

Preclinical Data NANOBIOTIX Nanoprimer Technology Systemic Bioavailability Toxicity Reduction
BRIEF

published on 04/07/2026 at 22:20, 6 months 15 days ago

État Mensuel des Droits de Vote et du Capital de Nanobiotix

Droits De Vote Euronext Capital Social Nasdaq NANOBIOTIX
BRIEF

published on 04/07/2026 at 22:20, 6 months 15 days ago

Monthly Statement of Voting Rights and Capital of Nanobiotix

Share Capital Voting Rights Euronext Nasdaq NANOBIOTIX
PRESS RELEASE

published on 04/07/2026 at 22:15, 6 months 15 days ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Nanobiotix publie ses données mensuelles sur les droits de vote et les actions. Détails sur la société de biotechnologie et ses activités

Euronext Paris Droits De Vote Biotechnologie Actions NANOBIOTIX
BRIEF

published on 03/30/2026 at 08:35, 6 months 24 days ago

NANOBIOTIX dévoile les premières données de son essai de phase 2 sur le cancer du poumon

Recherche Clinique Essai De Phase 2 NANOBIOTIX Cancer Du Poumon JNJ-1900 (NBTXR3)
BRIEF

published on 03/30/2026 at 08:35, 6 months 24 days ago

NANOBIOTIX Reveals Initial Data from Phase 2 Lung Cancer Trial

Clinical Research Phase 2 Trial NANOBIOTIX Lung Cancer JNJ-1900 (NBTXR3)
PRESS RELEASE

published on 03/30/2026 at 08:30, 6 months 24 days ago

NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
NANOBIOTIX announces first data from phase 2 trial on JNJ-1900 for stage 3 lung cancer presented by Johnson & Johnson at European Lung Cancer Conference

Phase 2 Trial NANOBIOTIX Lung Cancer Johnson & Johnson JNJ-1900
BRIEF

published on 03/26/2026 at 21:20, 6 months 27 days ago

NANOBIOTIX publiera ses résultats financiers et sa mise à jour pour 2025

Biotechnologie Conférence Téléphonique Mise À Jour Du Marché Résultats Financiers 2025 Traitements Par Nanoparticules

Accesswire

Published on 10/23/2026 at 02:20, 7 hours 21 minutes ago

Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 10 hours 11 minutes ago

Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 11 hours 11 minutes ago

Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 17 hours 41 minutes ago

Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 19 hours 11 minutes ago

Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components

View all ACCESSWIRE

EQS Group

Published on 10/23/2026 at 09:00, 41 minutes ago

Municipality Finance issues a USD 135 million tap under its MTN programme
Published on 10/23/2026 at 09:00, 41 minutes ago

Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY
Published on 10/23/2026 at 09:00, 41 minutes ago

Official List Notice
Published on 10/23/2026 at 08:30, 1 hour 11 minutes ago

ROCTOOL: COMPTE-RENDU DE L’ASSEMBLEE GENERALE EXTRAORDINAIRE DU 22 OCTOBRE 2026 DE ROCTOOL
Published on 10/23/2026 at 08:00, 1 hour 41 minutes ago

Cairn Homes Plc: Transaction in Own Shares

Les Echos

Published on 10/23/2026 at 07:00, 2 hours 41 minutes ago

Safran reports third quarter 2026 revenue
Published on 10/23/2026 at 07:00, 2 hours 41 minutes ago

Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 15 hours 41 minutes ago

THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 15 hours 41 minutes ago

THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 15 hours 41 minutes ago

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics

View all LES ECHOS COMFI WIRE